Maxim Grymonprez - Dissemin

All papers authored by Maxim Grymonprez

This paper was not found in any repository, but could be made available legally by the author.

2023 Maxim Grymonprez

, Stephane Steurbaut, Andreas Capiau, Delphine Vauterin

, Frauke Van Vaerenbergh, Els Mehuys, Koen Boussery, Tine L. De Backer, Lies Lahousse

Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study

Upload

This paper is made freely available by the publisher.

2022 Maxim Grymonprez

, Tine L. De Backer, Andreas Capiau

, Delphine Vauterin

, Els Mehuys

, Koen Boussery, Stephane Steurbaut, Lies Lahousse

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study

Download from academic.oup.com

2021 Maxim Grymonprez

, Kevin Vanspranghe, Stephane Steurbaut, Tine L. De Backer, Lies Lahousse

Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

A. Capiau, M. Grymonprez

, T. De Backer, S. Gevaert, K. Boussery, L. Lahousse

Voorkamerfibrillatie en niet-vitamine K-antagonist orale anticoagulantia: van klinische studies tot gebruik in de dagelijkse praktijk

Upload

Maxim Grymonprez

Niet-vitamine K-antagonist orale anticoagulantia bij oudere patiënten met voorkamerfibrillatie

Upload

Andreas Capiau, Tine De Backer, Maxim Grymonprez

, Lies Lahousse, Inge Van Tongelen, Els Mehuys, Koen Boussery

Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide

Upload

Maxim Grymonprez

, Andreas Capiau, Tine L. De Backer, Stephane Steurbaut

, Koen Boussery, Lies Lahousse

The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta‐analysis on the obesity paradox

Download from doi.org

Maxim Grymonprez

, Tine L. De Backer, Stephane Steurbaut, Koen Boussery, Lies Lahousse

Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis

Upload

2020 Maxim Grymonprez

, Stephane Steurbaut

, An De Sutter, Lies Lahousse

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis

Download from doi.org

Maxim Grymonprez

, Stephane Steurbaut

, Tine L. De Backer, Mirko Petrovic, Lies Lahousse

Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

Download from doi.org

2018 Maxim Grymonprez

, Vincent Vakaet

, Maryam Kavousi

, Bruno H. Stricker, M. Arfan Ikram, M. Arfan Ikram, Jan Heeringa, Oscar H. Franco, Guy G. Brusselle, Lies Lahousse

Chronic obstructive pulmonary disease and the development of atrial fibrillation

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Maxim Grymonprez